664 related articles for article (PubMed ID: 27217741)
1. Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.
Müllerová H; Landis SH; Aisanov Z; Davis KJ; Ichinose M; Mannino DM; Maskell J; Menezes AM; van der Molen T; Oh YM; Tabberer M; Han MK
Int J Chron Obstruct Pulmon Dis; 2016; 11():881-90. PubMed ID: 27217741
[TBL] [Abstract][Full Text] [Related]
2. Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management.
Menezes AM; Landis SH; Han MK; Muellerova H; Aisanov Z; van der Molen T; Oh YM; Ichinose M; Mannino DM; Davis KJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():159-72. PubMed ID: 25653515
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.
Stephenson JJ; Wertz D; Gu T; Patel J; Dalal AA
Int J Chron Obstruct Pulmon Dis; 2017; 12():1947-1959. PubMed ID: 28740375
[TBL] [Abstract][Full Text] [Related]
5. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.
Davis KJ; Landis SH; Oh YM; Mannino DM; Han MK; van der Molen T; Aisanov Z; Menezes AM; Ichinose M; Muellerova H
Int J Chron Obstruct Pulmon Dis; 2015; 10():39-55. PubMed ID: 25565799
[TBL] [Abstract][Full Text] [Related]
6. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.
Kokturk N; Polatli M; Oguzulgen IK; Saleemi S; Al Ghobain M; Khan J; Doble A; Tariq L; Aziz F; El Hasnaoui A
Int J Chron Obstruct Pulmon Dis; 2018; 13():1377-1388. PubMed ID: 29731625
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
Ágh T; Inotai A; Mészáros Á
Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
[TBL] [Abstract][Full Text] [Related]
8. Self-rated health aspects among persons living with chronic obstructive pulmonary disease.
Halding AG; Grov EK
Int J Chron Obstruct Pulmon Dis; 2017; 12():1163-1172. PubMed ID: 28442902
[TBL] [Abstract][Full Text] [Related]
9. COPD in Taiwan: a National Epidemiology Survey.
Cheng SL; Chan MC; Wang CC; Lin CH; Wang HC; Hsu JY; Hang LW; Chang CJ; Perng DW; Yu CJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():2459-67. PubMed ID: 26648708
[TBL] [Abstract][Full Text] [Related]
10. Determinants of activation for self-management in patients with COPD.
Korpershoek Y; Bos-Touwen ID; de Man-van Ginkel JM; Lammers JW; Schuurmans MJ; Trappenburg J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1757-66. PubMed ID: 27536087
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.
Koehorst-Ter Huurne K; Kort S; van der Palen J; van Beurden WJ; Movig KL; van der Valk P; Brusse-Keizer M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1679-88. PubMed ID: 27555758
[TBL] [Abstract][Full Text] [Related]
12. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.
Landis SH; Muellerova H; Mannino DM; Menezes AM; Han MK; van der Molen T; Ichinose M; Aisanov Z; Oh YM; Davis KJ
Int J Chron Obstruct Pulmon Dis; 2014; 9():597-611. PubMed ID: 24944511
[TBL] [Abstract][Full Text] [Related]
13. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
14. Greater dyspnea is associated with lower health-related quality of life among European patients with COPD.
Gruenberger JB; Vietri J; Keininger DL; Mahler DA
Int J Chron Obstruct Pulmon Dis; 2017; 12():937-944. PubMed ID: 28360517
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic burden of COPD for patients receiving dual or triple therapy.
Chen S; Small M; Lindner L; Xu X
Int J Chron Obstruct Pulmon Dis; 2018; 13():1365-1376. PubMed ID: 29731624
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
[TBL] [Abstract][Full Text] [Related]
17. Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.
Montes de Oca M; Menezes A; Wehrmeister FC; Lopez Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Surmont F; Miravitlles M
PLoS One; 2017; 12(11):e0186777. PubMed ID: 29140978
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.
Davis E; Marra C; Gamble JM; Farrell J; Lockyer J; FitzGerald JM; Abu-Ashour W; Gillis C; Hawboldt J
Trials; 2016 Oct; 17(1):502. PubMed ID: 27737686
[TBL] [Abstract][Full Text] [Related]
19. Can a supported self-management program for COPD upon hospital discharge reduce readmissions? A randomized controlled trial.
Johnson-Warrington V; Rees K; Gelder C; Morgan MD; Singh SJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1161-9. PubMed ID: 27330284
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
